NADPH oxidase inhibition prevents cocaine-induced up-regulation of xanthine oxidoreductase and cardiac dysfunction

被引:45
作者
Isabelle, Marc
Vergeade, Aurelia
Moritz, Fabienne
Dautreaux, Brigitte
Henry, Jean-Paul
Lallemand, Francoise
Richard, Vincent
Mulder, Paul
Thuillez, Christian
Monteil, Christelle
机构
[1] UFR Med & Pharm, INSERM U644, F-76183 Rouen, France
[2] Univ Rouen, F-76183 Rouen, France
关键词
cocaine; oxidative stress; NADPH oxidase; xanthine oxidase; cardiac function; reactive oxygen species;
D O I
10.1016/j.yjmcc.2006.11.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Oxidative stress is involved in the pathogenesis of cocaine-induced cardiomyopathy. In the present study, we aimed to determine the enzymatic sources of reactive oxygen species (ROS) production, namely NADPH oxidase and xanthine oxidoreductase (XOR) in male Wistar rats treated for 7 days with cocaine (2 x 7.5 mg/kg/day, ip) or cocaine with a NADPH oxidase inhibitor (apocynin, 50 mg/kg/day, po) or a XOR inhibitor (allopurinol, 50 mg/kg/day, po). Cocaine-induced cardiac dysfunction is associated with an increase in NADPH oxidase and XOR activities (59% and 29%, respectively) and a decrease in catalase activity. Apocynin or allopurinol treatment prevents the cocaine-induced cardiac alteration by restoration of cardiac output, stroke volume and fractional shortening. This is associated with a reduction of the myocardial production of superoxide anions and an enhancement of catalase activity. Surprisingly, apocynin treatment prevents XOR up-regulation supporting the hypothesis that NADPH oxidase-derived ROS play a role in modulating ROS production by XOR. These data suggest that NADPH and xanthine oxidase act synergically to form myocardial ROS and clearly demonstrate that their inhibition may be critical in preventing the initiation and progression of cocaine-induced LV dysfunction. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:326 / 332
页数:7
相关论文
共 35 条
[1]  
AEBI H, 1984, METHOD ENZYMOL, V105, P121
[2]   Xanthine oxidase inhibition ameliorates cardiovascular dysfunction in dogs with pacing-induced heart failure [J].
Amado, LC ;
Saliaris, AP ;
Raju, SVY ;
Lehrke, S ;
John, MS ;
Xie, JS ;
Stewart, G ;
Fitton, T ;
Minhas, KM ;
Brawn, J ;
Hare, JM .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2005, 39 (03) :531-536
[3]   Reactive oxygen species mediate alpha-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes [J].
Amin, JK ;
Xiao, L ;
Pimental, DR ;
Pagano, PJ ;
Singh, K ;
Sawyer, DB ;
Colucci, WS .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2001, 33 (01) :131-139
[4]   A SENSITIVE FLUOROMETRIC ASSAY FOR MEASURING XANTHINE DEHYDROGENASE AND OXIDASE IN TISSUES [J].
BECKMAN, JS ;
PARKS, DA ;
PEARSON, JD ;
MARSHALL, PA ;
FREEMAN, BA .
FREE RADICAL BIOLOGY AND MEDICINE, 1989, 6 (06) :607-615
[5]   Toxicology update: the cardiotoxicity of the oxidative stress metabolites of catecholamines (aminochromes) [J].
Behonick, GS ;
Novak, MJ ;
Nealley, EW ;
Baskin, SI .
JOURNAL OF APPLIED TOXICOLOGY, 2001, 21 :S15-S22
[6]   Catecholamine-induced vascular wall growth is dependent on generation of reactive oxygen species [J].
Bleeke, T ;
Zhang, H ;
Madamanchi, N ;
Patterson, C ;
Faber, JE .
CIRCULATION RESEARCH, 2004, 94 (01) :37-45
[7]   Vascular NADPH oxidases: molecular mechanisms of activation [J].
Brandes, RP ;
Kreuzer, J .
CARDIOVASCULAR RESEARCH, 2005, 65 (01) :16-27
[8]   The vascular NAD(P)H oxidases as therapeutic targets cardiovascular diseases [J].
Cai, H ;
Griendling, KK ;
Harrison, DG .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2003, 24 (09) :471-478
[9]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[10]   Effect of the NAD(P)H oxidase inhibitor, apocynin, on peripheral nerve perfusion and function in diabetic rats [J].
Cotter, MA ;
Cameron, NE .
LIFE SCIENCES, 2003, 73 (14) :1813-1824